Benefits of various dextrans after delayed therapy in necrotizing pancreatitis of the rat

Ultrahigh-molecular dextran (500 000 DA) has been shown to prevent pancreatic necrosis when given 30 min after induction of pancreatitis. This study should clarify the following: (a) are dextrans still effective after prolongation of the therapy-free interval? (b) what is the impact of the molecular...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Schmidt, Jan (VerfasserIn) , Huch, Kristina (VerfasserIn) , Mithöfer, Kai (VerfasserIn) , Hotz, Hubert G. (VerfasserIn) , Sinn, Peter (VerfasserIn) , Buhr, Heinz J. (VerfasserIn) , Warshaw, A. L. (VerfasserIn) , Herfarth, Christian (VerfasserIn) , Klar, Ernst (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: November 1996
In: Intensive care medicine
Year: 1996, Jahrgang: 22, Heft: 11, Pages: 1207-1213
ISSN:1432-1238
DOI:10.1007/BF01709338
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/BF01709338
Volltext
Verfasserangaben:J. Schmidt, K. Huch, K. Mithöfer, H.G. Hotz, H.P. Sinn, H.J. Buhr, A.L. Warshaw, C. Herfarth, E. Klar
Beschreibung
Zusammenfassung:Ultrahigh-molecular dextran (500 000 DA) has been shown to prevent pancreatic necrosis when given 30 min after induction of pancreatitis. This study should clarify the following: (a) are dextrans still effective after prolongation of the therapy-free interval? (b) what is the impact of the molecular weight of the dextrans? and (c) is their effect influenced by the dextran concentration or by the addition of hypertonic saline?
Beschreibung:Gesehen am 20.08.2025
Beschreibung:Online Resource
ISSN:1432-1238
DOI:10.1007/BF01709338